Pharma companies offer drugs at low or no cost

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.395, 2003-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

WTO agreement on access to low-cost drugs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 429, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Brazil saved $US1 billion between 2001 and 2005 due to its government's policy of bargaining with pharma companies over the cost of antiretrovirals

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 542, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

EU price controls, low-cost drugs for developing countries

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 416, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

China encourages price competition between pharma companies

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 284, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Pharma companies pulling the strings in clinical research

Inpharma, Vol. 1, Iss. 1656, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite